Anti-Inflammatory and Analgesic Activities of Terminalia Muelleri Benth. (Combretaceae)

Drug Dev Res. 2017 Jun;78(3-4):146-154. doi: 10.1002/ddr.21385. Epub 2017 May 19.

Abstract

Preclinical Research The anti-inflammatory and analgesic activities of a polyphenol-rich fraction (TMEF) obtained from Terminalia muelleri Benth. were measured. The analgesic activity of TMEF was tested using acetic acid-induced writhing and hot plate models in mice. The anti-inflammatory activity was assessed using carrageenan-induced paw edema model by measuring PGE2 , TNF-α, IL-1β, and IL-6 plasma levels as well as the paw thickness. TMEF was tested at doses of 100, 200, and 400 mg/kg p.o. and diclofenac sodium was used as a standard (100 mg/kg) in all experiments. The group treated with 400 mg/kg of TMEF showed a greater inhibition in the number of writhes (by 63%) than the standard-treated group (61%). Pretreatment with TMEF increased the analgesic effect in hot plate test in a dose-dependent manner with a maximum effect after 120 min. TMEF pretreatment alos reduced the edema thickness by 48, 53, and 62% at the tested doses, respectively. TMEF administration inhibited the carrageenan-induced elevations in PGE2 (by 34, 43, and 47%), TNF-α (18, 28, and 41%), IL-1β (14, 22, and 29%), and IL-6 (26, 31, and 46%). Four phenolic compounds were isolated from Terminalia muelleri for the first time. Drug Dev Res 78 : 146-154, 2017. © 2017 Wiley Periodicals, Inc.

Keywords: carrageenan; chebulinic acid; cytokines; hot-plate test; isoorientin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics / administration & dosage*
  • Analgesics / chemistry
  • Analgesics / pharmacology
  • Animals
  • Anti-Inflammatory Agents / administration & dosage*
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / pharmacology
  • Carrageenan / adverse effects
  • Disease Models, Animal
  • Edema / chemically induced
  • Edema / drug therapy*
  • Edema / immunology
  • Gene Expression Regulation / drug effects
  • Humans
  • Interleukin-1beta / metabolism
  • Interleukin-6 / metabolism
  • Male
  • Mice
  • Plant Extracts / administration & dosage
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology
  • Polyphenols / administration & dosage*
  • Polyphenols / chemistry
  • Polyphenols / pharmacology
  • Terminalia / chemistry*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Analgesics
  • Anti-Inflammatory Agents
  • IL1B protein, mouse
  • Interleukin-1beta
  • Interleukin-6
  • Plant Extracts
  • Polyphenols
  • Tumor Necrosis Factor-alpha
  • interleukin-6, mouse
  • Carrageenan